Best treatments for melanoma
13 products may treat melanoma, spanning FDA drug classes such as programmed death receptor-1 blocking antibody, kinase inhibitor, microtubule inhibitor. The current highest-rated option is opdivo. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 13 drugs we list for melanoma, 1 is available as lower-cost generics, spanning classes such as programmed death receptor-1 blocking antibody, kinase inhibitor, microtubule inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for melanoma — so confirm the right choice with your prescriber.
Understanding melanoma
Melanoma is a serious form of skin cancer that begins in melanocytes, the cells that give skin its color, according to the National Cancer Institute (NCI). It usually forms on the skin but can also develop in the eyes (intraocular or uveal melanoma) and, less commonly, at other sites. Being exposed to natural sunlight or artificial sources such as tanning beds is a documented risk factor. NCI notes that melanoma is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer. Often the first sign is a change in the size, shape, color, or feel of a mole, or a new, unusual growth. The "ABCDE" features help flag concern: Asymmetry, Border irregularity, Color variation, Diameter (melanoma is usually larger than 6 millimeters), and Evolving (changing over time). A clinician evaluates suspicious spots with a skin exam and confirms melanoma with a skin biopsy. If melanoma is found, further testing—including tumor thickness, whether the tumor is ulcerated, and sometimes a sentinel lymph node biopsy—helps determine the stage. This is general information, not medical advice.
First-line treatment
Treatment is individualized. According to the National Cancer Institute (NCI) and the American Cancer Society, the plan is chosen based on the stage of the cancer—including tumor thickness, ulceration, lymph node involvement, and whether it has spread—and other factors. NCI notes that treatment and prognosis can also depend on whether the cancer has certain mutations in a gene called BRAF. Based on these factors, options fall into several categories: surgery, immunotherapy, targeted therapy, chemotherapy, and radiation therapy. Early-stage melanomas can often be treated with surgery alone, while more advanced cancers often require other treatments. The American Cancer Society notes that care may involve a multidisciplinary team, which can include dermatologists, surgical oncologists, medical oncologists, and radiation oncologists, who tailor the plan to each patient. No single drug or regimen is "the" treatment for everyone. This is general information, not medical advice.
Top-rated picks for melanoma: 1. Opdivo · 2. Cotellic · 3. Mekinist
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Programmed Death Receptor-1 Blocking Antibody | No data | — | View → | |
| 2 | 70/100 | Prescription | Tablet | Kinase Inhibitor | No data | — | View → | |
| 3 | 70/100 | Prescription | Solution | Kinase Inhibitor | No data | — | View → | |
| 4 | 70/100 | Prescription | Capsule | — | No data | — | View → | |
| 5 | 70/100 | Prescription | Injectable | Microtubule Inhibitor | No data | — | View → | |
| 6 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 7 | Not yet rated | Prescription | Capsule | — | No data | — | View → | |
| 8 | Not yet rated | Prescription | Injectable | Microtubule Inhibitor | No data | — | View → | |
| 9 | Not yet rated | Prescription | Capsule | — | No data | — | View → | |
| 10 | Not yet rated | Prescription | Tablet | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: microtubule inhibitor · kinase inhibitor
Full ranking · 13 treatments
opdivo
PrescriptionFDA-sourced
Opdivo (Nivolumab) is a programmed death receptor-1 blocking antibody used to treat Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms.
Price varies
cotellic
PrescriptionFDA-sourced
Cotellic (Cobimetinib Fumarate) is a kinase inhibitor used to treat Melanoma.
Price varies
mekinist
PrescriptionFDA-sourced
Mekinist (Trametinib Dimethyl Sulfoxide) is a kinase inhibitor used to treat Non-Small-Cell Lung Carcinoma, Melanoma.
Price varies
tafinlar
PrescriptionFDA-sourced
Tafinlar (Dabrafenib Mesylate) is a medication used to treat Melanoma.
Price varies
taxotere
Boxed warningPrescriptionFDA-sourced
Taxotere (Docetaxel) is a microtubule inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms, Melanoma.
Price varies
tecentriq
PrescriptionFDA-sourced
Tecentriq (Atezolizumab) is a medication used to treat Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma, Melanoma.
Price varies
Frequently asked
- What treats melanoma?
- Our catalog lists 13 products that may treat melanoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is opdivo.
- What is the best-rated treatment for melanoma?
- By our independent recall-safety rating — not an efficacy measure — opdivo ranks highest among the products we list for melanoma. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat melanoma?
- Treatments for melanoma span FDA drug classes including programmed death receptor-1 blocking antibody, kinase inhibitor, microtubule inhibitor, lymphocyte growth factor, alkylating drug. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.